CTOs on the Move

LetsGetChecked

www.letsgetchecked.com

 
LetsGetChecked is a virtual care company that allows customers to manage their health from home, providing direct access to telehealth services, pharmacy, and laboratory tests with at-home sample collection kits for a wide range of health conditions including Sexual Health, Cholesterol, Diabetes, Thyroid, Coronavirus (COVID-19), and more. Founded in 2015, the company empowers people with the care they need to live longer, happier lives. Today, LetsGetChecked is a leader in healthcare innovation with an end-to-end model including manufacturing, logistics, lab analysis, affiliated physician support, and prescription fulfillment, which provides a seamless user experience and a convenient, reliable and secure ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

LetsGetChecked raised $12M on 03/28/2018
LetsGetChecked raised $30M on 05/08/2019
LetsGetChecked raised $71M on 05/05/2020
LetsGetChecked raised $150M on 06/08/2021

Similar Companies

MedHunters

MedHunters is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hunterdon Healthcare

The Hunterdon Healthcare System is a non-profit health care organization in Flemington, NJ committed to providing a full range of quality services that respond to the needs of the community. Hunterdon Medical Center is a 178-bed non-profit community hospital, providing a full range of preventive, diagnostic, and therapeutic inpatient and outpatient hospital and community health services.

Condor (Canada) Medical Co.

Condor (Canada) Medical Co., Ltd. is a Abbotsford, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Protac Fitness

PROTAC, LLC, Is a 100% veteran-owned small business that offers a variety of training and health programs for service members and athletes.